Join today and be a part of the fastest growing B2B Network Join Now

Abemaciclib

  • Origin: United States
  • Supply Type: oem service

Supplier Info.

  • Employees Total 5
  • Annual Revenue US$2.5 Million - US$5 Million

Abemaciclib is a drug for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly and it acts as a CDK inhibitor selective for CDK4 and CDK6. It was designated as a breakthrough therapy for breast cancer by the U.S. Food and Drug

Premium Services
Need Suppliers
Girl Right
Cross Popup
Arrow 2

I Am :

Signup today to claim your Discount. Get Started before it's too late!

Arrow 1
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok